Merck Bets $250M On Next-Gen Approach To mRNA For Infectious Diseases, Cancer
Merck Co & Inc (NYSE:MRK) and Orna Therapeutics announced a collaboration agreement to discover, develop, and commercialize multiple programs, including vaccines and therapeutics…